Works by Griesinger, Frank

Results: 74
    1
    2

    Efficacy and Safety of Brigatinib Compared With Crizotinib in Asian vs. Non-Asian Patients With Locally Advanced or Metastatic ALK-Inhibitor-Naive ALK+ Non-Small Cell Lung Cancer: Final Results From the Phase III ALTA-1L Study.

    Published in:
    Clinical Lung Cancer, 2022, v. 23, n. 8, p. 720, doi. 10.1016/j.cllc.2022.07.008
    By:
    • Myung J. Ahn;
    • Hye R. Kim;
    • Yang, James C. H.;
    • Ji-Yu Han;
    • Yu-Chung. Li, Jacky;
    • Hochmair, Maximilian J.;
    • Gee-Chen Chang;
    • Delmonte, Angelo;
    • Ki H. Lee;
    • Campelo, Rosario G.;
    • Gridelli, Cesare;
    • Spira, Alexander I.;
    • Califano, Raffaele;
    • Griesinger, Frank;
    • Ghosh, Sharmistha;
    • Felip, Enriqueta;
    • Dong-Wan Kim;
    • Yuyin Liu;
    • Pingkuan Zhang;
    • Popat, Sanjay
    Publication type:
    Article
    3
    4

    ctDNA Dynamics, Prognostic Markers, and Mechanisms of Resistance in Tepotinib-treated MET exon 14 (METex14) Skipping NSCLC in the VISION Trial.

    Published in:
    Journal of Oncology Navigation & Survivorship, 2023, v. 14, n. 11, p. 352
    By:
    • Xiuning Le;
    • Garassino, Marina Chiara;
    • Myung-Ju Ahn;
    • Felip, Enriqueta;
    • Cortot, Alexis B.;
    • Hiroshi Sakai;
    • Mazières, Julien;
    • Thomas, Michael;
    • Viteri, Santiago;
    • Conte, Pierfranco;
    • Chih-Hsin Yang, James;
    • Iams, Wade Thomas;
    • Griesinger, Frank;
    • Braggio, Danielle;
    • Stroh, Christopher;
    • Juraeva, Dilafruz;
    • Wang, Danyi;
    • Johne, Andreas;
    • Paik, Paul K.
    Publication type:
    Article
    5

    Detection of ESR1 Mutations in Tissue and Liquid Biopsy with Novel Next-Generation Sequencing and Digital Droplet PCR Assays: Insights from Multi-Center Real Life Data of Almost 6000 Patients.

    Published in:
    Cancers, 2025, v. 17, n. 8, p. 1266, doi. 10.3390/cancers17081266
    By:
    • Borkar, Srushti;
    • Markus, Fenja;
    • Oetting, Agnes;
    • Schmidt, Stefanie;
    • Vössing, Christine;
    • Horst, David;
    • Möbs, Markus;
    • Braicu, Elena I.;
    • Griesinger, Frank;
    • Horling, Katja;
    • Tiemann, Katharina;
    • Heukamp, Lukas C.;
    • Willing, Eva-Maria;
    • Vollbrecht, Claudia
    Publication type:
    Article
    6

    Effectiveness of Nivolumab in Second-Line and Later in Patients with Advanced Non-Small Cell Lung Cancer in Real-Life Practice in France and Germany: Analysis of the ESME-AMLC and CRISP Cohorts.

    Published in:
    Cancers, 2022, v. 14, n. 24, p. 6148, doi. 10.3390/cancers14246148
    By:
    • Chouaid, Christos;
    • Thomas, Michael;
    • Debieuvre, Didier;
    • Durand-Zaleski, Isabelle;
    • Zacharias, Stefan;
    • Bosquet, Lise;
    • Groth, Annika;
    • Fleitz, Annette;
    • Calleja, Alan;
    • Patel, Sonya;
    • Lacoin, Laure;
    • Daumont, Melinda J.;
    • Penrod, John R.;
    • Carroll, Robert;
    • Waldenberger, Daniela;
    • Cotté, François-Emery;
    • Audigier-Valette, Clarisse;
    • Griesinger, Frank
    Publication type:
    Article
    7
    8
    9
    10

    Clinical activity of a htert (vx-001) cancer vaccine as post-chemotherapy maintenance immunotherapy in patients with stage IV non-small cell lung cancer: final results of a randomised phase 2 clinical trial.

    Published in:
    2020
    By:
    • Gridelli, Cesare;
    • Ciuleanu, Tudor;
    • Domine, Manuel;
    • Szczesna, Aleksandra;
    • Bover, Isabel;
    • Cobo, Manuel;
    • Kentepozidis, Nikolaos;
    • Zarogoulidis, Konstantinos;
    • Kalofonos, Charalabos;
    • Kazarnowisz, Andrzej;
    • Korozan, Magdalena;
    • de las Penas, Ramon;
    • Majem, Margarita;
    • Chella, Antonio;
    • Griesinger, Frank;
    • Bournakis, Evangelos;
    • Sadjadian, Parvis;
    • Kotsakis, Athanasios;
    • Chinet, Thierry;
    • Syrigos, Kostantinos N.
    Publication type:
    journal article
    11

    An Adjusted Treatment Comparison Comparing Amivantamab Versus Real-World Clinical Practice in Europe and the United States for Patients with Advanced Non-Small Cell Lung Cancer with Activating Epidermal Growth Factor Receptor Exon 20 Insertion Mutations.

    Published in:
    Advances in Therapy, 2023, v. 40, n. 3, p. 1187, doi. 10.1007/s12325-022-02408-7
    By:
    • Chouaid, Christos;
    • Bosquet, Lise;
    • Girard, Nicolas;
    • Kron, Anna;
    • Scheffler, Matthias;
    • Griesinger, Frank;
    • Sebastian, Martin;
    • Trigo, Jose;
    • Viteri, Santiago;
    • Knott, Craig;
    • Rodrigues, Bernardo;
    • Rahhali, Nora;
    • Cabrieto, Jedelyn;
    • Diels, Joris;
    • Perualila, Nolen J.;
    • Schioppa, Claudio A.;
    • Sermon, Jan;
    • Toueg, Raphael;
    • Erdmann, Nicole;
    • Mielke, Janka
    Publication type:
    Article
    12
    13

    The cloud application modelling and execution language.

    Published in:
    Journal of Cloud Computing (2192-113X), 2019, v. 8, n. 1, p. 1, doi. 10.1186/s13677-019-0138-7
    By:
    • Achilleos, Achilleas P.;
    • Kritikos, Kyriakos;
    • Rossini, Alessandro;
    • Kapitsaki, Georgia M.;
    • Domaschka, Jörg;
    • Orzechowski, Michal;
    • Seybold, Daniel;
    • Griesinger, Frank;
    • Nikolov, Nikolay;
    • Romero, Daniel;
    • Papadopoulos, George A.
    Publication type:
    Article
    14

    Multi-cloud provisioning of business processes.

    Published in:
    Journal of Cloud Computing (2192-113X), 2019, v. 8, n. 1, p. N.PAG, doi. 10.1186/s13677-019-0143-x
    By:
    • Kritikos, Kyriakos;
    • Zeginis, Chrysostomos;
    • Iranzo, Joaquin;
    • Gonzalez, Roman Sosa;
    • Seybold, Daniel;
    • Griesinger, Frank;
    • Domaschka, Jörg
    Publication type:
    Article
    15

    A randomized, multicenter phase II study comparing efficacy, safety and tolerability of two dosing regimens of cisplatin and pemetrexed in patients with advanced or metastatic non-small-cell lung cancer.

    Published in:
    Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/1758835921996506
    By:
    • Metzenmacher, Martin;
    • Kopp, Hans-Georg;
    • Griesinger, Frank;
    • Reinmuth, Niels;
    • Sebastian, Martin;
    • Serke, Monika;
    • Waller, Cornelius Florian;
    • Thomas, Michael;
    • Eggert, Jochen;
    • Schmid-Bindert, Gerald;
    • Hoiczyk, Mathias;
    • Christoph, Daniel Christian;
    • Kimmich, Martin;
    • Deuß, Burkhard;
    • Seifert, Stephanie;
    • Held, Swantje;
    • Schuler, Martin;
    • Herold, Thomas;
    • Breitenbuecher, Frank;
    • Eberhardt, Wilfried Ernst Erich
    Publication type:
    Article
    16
    17

    Lorlatinib in pretreated ALK- or ROS1-positive lung cancer and impact of TP53 co-mutations: results from the German early access program.

    Published in:
    Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/1758835920980558
    By:
    • Frost, Nikolaj;
    • Christopoulos, Petros;
    • Kauffmann-Guerrero, Diego;
    • Stratmann, Jan;
    • Riedel, Richard;
    • Schaefer, Monica;
    • Alt, Jürgen;
    • Gütz, Sylvia;
    • Christoph, Daniel C.;
    • Laack, Eckart;
    • Faehling, Martin;
    • Fischer, Richard;
    • Fenchel, Klaus;
    • Haen, Sebastian;
    • Heukamp, Lukas;
    • Schulz, Christian;
    • Griesinger, Frank
    Publication type:
    Article
    18
    19
    20
    21
    22
    23
    24

    Clinical Experience of Immunotherapy Treatment: Efficacy and Toxicity Analysis of the Compassionate Use Program of Nivolumab in Patients with Advanced Squamous Cell Non-Small Cell Lung Cancer.

    Published in:
    Oncology Research & Treatment, 2019, v. 42, n. 5, p. 243, doi. 10.1159/000499321
    By:
    • Krefting, Frederik;
    • Basara, Nadezda;
    • Schütte, Wolfgang;
    • Späth-Schwalbe, Ernst;
    • Alt, Jürgen;
    • Thiel, Sebastian;
    • Kimmich, Martin;
    • Fischer, Jürgen R.;
    • Kurz, Sylke;
    • Griesinger, Frank;
    • Christoph, Daniel C.
    Publication type:
    Article
    25

    Clinical Experience of Immunotherapy Treatment: Efficacy and Toxicity Analysis of the Compassionate Use Program of Nivolumab in Patients with Advanced Squamous Cell Non-Small Cell Lung Cancer.

    Published in:
    Oncology Research & Treatment, 2019, v. 42, n. 4, p. 243, doi. 10.1159/000499321
    By:
    • Krefting, Frederik;
    • Basara, Nadezda;
    • Schütte, Wolfgang;
    • Späth-Schwalbe, Ernst;
    • Alt, Jürgen;
    • Thiel, Sebastian;
    • Kimmich, Martin;
    • Fischer, Jürgen R.;
    • Kurz, Sylke;
    • Griesinger, Frank;
    • Christoph, Daniel C.
    Publication type:
    Article
    26

    Tumorkonferenz I.

    Published in:
    Oncology Research & Treatment, 2013, v. 36, p. 2, doi. 10.1159/000353714
    By:
    • Overbeck, Tobias;
    • Schäper, Christoph;
    • Griesinger, Frank;
    • Gröschel, andreas;
    • Haug, alexander;
    • Leschber, Gunda;
    • Pfluger, Thomas;
    • Pöttgen, Christoph
    Publication type:
    Article
    27

    Vorwort.

    Published in:
    Oncology Research & Treatment, 2013, v. 36, p. 1, doi. 10.1159/000353713
    By:
    • Griesinger, Frank;
    • Huber, Rudolf M.;
    • Thomas, Michael;
    • Wolf, Martin
    Publication type:
    Article
    28

    Biased distribution of chromosomal breakpoints involving the MLL gene in infants versus children and adults with t(4;11) ALL.

    Published in:
    Oncogene, 2001, v. 20, n. 23, p. 2900, doi. 10.1038/sj.onc.1204401
    By:
    • Reichel, Martin;
    • Gillert, Esther;
    • Angermüller, Sieglinde;
    • Hensel, Jan Patrick;
    • Heidel, Florian;
    • Lode, Martin;
    • Leis, Thomas;
    • Biondi, Andrea;
    • Haas, Oskar A;
    • Strehl, Sabine;
    • Panzer-Grümayer, E Renate;
    • Griesinger, Frank;
    • Beck, Jörn D;
    • Greil, Johann;
    • Fey, Georg H;
    • Uckun, Fatih M;
    • Marschalek, Rolf
    Publication type:
    Article
    29
    30
    31

    A randomized, multicenter phase II study comparing efficacy, safety and tolerability of two dosing regimens of cisplatin and pemetrexed in patients with advanced or metastatic non-small-cell lung cancer.

    Published in:
    Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/1758835921996506
    By:
    • Metzenmacher, Martin;
    • Kopp, Hans-Georg;
    • Griesinger, Frank;
    • Reinmuth, Niels;
    • Sebastian, Martin;
    • Serke, Monika;
    • Waller, Cornelius Florian;
    • Thomas, Michael;
    • Eggert, Jochen;
    • Schmid-Bindert, Gerald;
    • Hoiczyk, Mathias;
    • Christoph, Daniel Christian;
    • Kimmich, Martin;
    • Deuß, Burkhard;
    • Seifert, Stephanie;
    • Held, Swantje;
    • Schuler, Martin;
    • Herold, Thomas;
    • Breitenbuecher, Frank;
    • Eberhardt, Wilfried Ernst Erich
    Publication type:
    Article
    32

    Lorlatinib in pretreated ALK- or ROS1-positive lung cancer and impact of TP53 co-mutations: results from the German early access program.

    Published in:
    Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/1758835920980558
    By:
    • Frost, Nikolaj;
    • Christopoulos, Petros;
    • Kauffmann-Guerrero, Diego;
    • Stratmann, Jan;
    • Riedel, Richard;
    • Schaefer, Monica;
    • Alt, Jürgen;
    • Gütz, Sylvia;
    • Christoph, Daniel C.;
    • Laack, Eckart;
    • Faehling, Martin;
    • Fischer, Richard;
    • Fenchel, Klaus;
    • Haen, Sebastian;
    • Heukamp, Lukas;
    • Schulz, Christian;
    • Griesinger, Frank
    Publication type:
    Article
    33
    34

    Radioimmunotherapy of small-volume disease of metastatic colorectal cancer.

    Published in:
    Cancer (0008543X), 2002, v. 94, n. S4, p. 1373, doi. 10.1002/cncr.10308
    By:
    • Behr, Thomas M.;
    • Liersch, Torsten;
    • Greiner-Bechert, Lutz;
    • Griesinger, Frank;
    • Béhé, Martin;
    • Markus, Peter M.;
    • Gratz, Stefan;
    • Angerstein, Christa;
    • Brittinger, Gerhard;
    • Becker, Heinz;
    • Goldenberg, David M.;
    • Becker, Wolfgang
    Publication type:
    Article
    35
    36

    Outcomes of anti‐programmed death 1 treatment for relapsed/refractory Hodgkin lymphoma: A German Hodgkin Study Group multicentre real‐world analysis.

    Published in:
    British Journal of Haematology, 2022, v. 198, n. 2, p. 401, doi. 10.1111/bjh.18231
    By:
    • Momotow, Jesko;
    • Bühnen, Ina;
    • Trautmann‐Grill, Karolin;
    • Kobbe, Guido;
    • Hahn, Dennis;
    • Schroers, Roland;
    • Heinrich, Bernhard;
    • Gaska, Tobias;
    • Forstbauer, Helmut;
    • Schmidt, Burkhard;
    • Boger, Regina;
    • Hüttmann, Andreas;
    • Heil, Gerhard;
    • Kraemer, Doris M.;
    • Krüger, William;
    • Zeremski, Vanja;
    • Grobe, Norbert;
    • Jentsch‐Ullrich, Kathleen;
    • Griesinger, Frank;
    • Fuchs, Michael
    Publication type:
    Article
    37
    38

    Tandem high-dose therapy in relapsed and refractory B-cell lymphoma: results of a prospective phase II trial of myeloablative chemotherapy, followed by escalated radioimmunotherapy with I-anti-CD20 antibody and stem cell rescue.

    Published in:
    Annals of Hematology, 2011, v. 90, n. 11, p. 1307, doi. 10.1007/s00277-011-1199-y
    By:
    • Hohloch, Karin;
    • Sahlmann, Carsten;
    • Lakhani, Vijai;
    • Wulf, Gerald;
    • Glaß, Bertram;
    • Hasenkamp, Justin;
    • Meller, Johannes;
    • Riggert, Joachim;
    • Trümper, Lorenz;
    • Griesinger, Frank
    Publication type:
    Article
    39
    40
    41
    42

    Patient‐reported outcomes in advanced NSCLC before and during the COVID‐19 pandemic: Real‐world data from the German prospective CRISP Registry (AIO‐TRK‐0315).

    Published in:
    International Journal of Cancer, 2024, v. 154, n. 11, p. 1967, doi. 10.1002/ijc.34868
    By:
    • Sebastian, Martin;
    • Eberhardt, Wilfried E. E.;
    • von der Heyde, Eyck;
    • Dörfel, Steffen;
    • Wiegand, Jörg;
    • Schiefer, Clemens;
    • Losem, Christoph;
    • Jänicke, Martina;
    • Fleitz, Annette;
    • Zacharias, Stefan;
    • Kaiser‐Osterhues, Anja;
    • Hipper, Annette;
    • Dietel, Corinna;
    • Bleckmann, Annalen;
    • Benkelmann, Robin;
    • Boesche, Michael;
    • Grah, Christian;
    • Müller, Annette;
    • Griesinger, Frank;
    • Thomas, Michael
    Publication type:
    Article
    43
    44
    45

    Decision Conflicts in Clinical Care during COVID-19: A Multi-Perspective Inquiry.

    Published in:
    Healthcare (2227-9032), 2022, v. 10, n. 10, p. N.PAG, doi. 10.3390/healthcare10101914
    By:
    • Haier, Joerg;
    • Beller, Johannes;
    • Adorjan, Kristina;
    • Bleich, Stefan;
    • de Greck, Moritz;
    • Griesinger, Frank;
    • Heppt, Markus;
    • Hurlemann, René;
    • Mees, Soeren Torge;
    • Philipsen, Alexandra;
    • Rohde, Gernot;
    • Schilling, Georgia;
    • Trautmann, Karolin;
    • Combs, Stephanie E.;
    • Geyer, Siegfried;
    • Schaefers, Juergen
    Publication type:
    Article
    46

    Decision Conflicts in Clinical Care during COVID-19: A Patient Perspective.

    Published in:
    Healthcare (2227-9032), 2022, v. 10, n. 6, p. 1019, doi. 10.3390/healthcare10061019
    By:
    • Haier, Jörg;
    • Beller, Johannes;
    • Adorjan, Kristina;
    • Bleich, Stefan;
    • De Greck, Moritz;
    • Griesinger, Frank;
    • Hein, Alexander;
    • Hurlemann, René;
    • Mees, Sören Torge;
    • Philipsen, Alexandra;
    • Rohde, Gernot;
    • Schilling, Georgia;
    • Trautmann, Karolin;
    • Combs, Stephanie E.;
    • Geyer, Siegfried;
    • Schäfers, Jürgen
    Publication type:
    Article
    47
    48
    49
    50

    Transportability of Overall Survival Estimates From US to Canadian Patients With Advanced Non–Small Cell Lung Cancer With Implications for Regulatory and Health Technology Assessment.

    Published in:
    JAMA Network Open, 2022, v. 5, n. 11, p. e2239874, doi. 10.1001/jamanetworkopen.2022.39874
    By:
    • Ramagopalan, Sreeram V.;
    • Popat, Sanjay;
    • Gupta, Alind;
    • Boyne, Devon J.;
    • Lockhart, Alexandre;
    • Hsu, Grace;
    • O'Sullivan, Dylan E.;
    • Inskip, Jessica;
    • Ray, Joshua;
    • Cheung, Winson Y.;
    • Griesinger, Frank;
    • Subbiah, Vivek
    Publication type:
    Article